
The Foundation for NIH Launches I-SPY 2 Breast Cancer Clinical Trial Highly Anticipated Multi-Agent Trial Opens at Major U.S. Medical Sites Groundbreaking Public-Private Collaboration Combines Personalized Medicine and Novel Trial Design to Develop Potentially Life Saving New Breast Cancer Drugs View Webcast of the March 17th Press Event by Visiting One of the Following Sites:
|
To register for this event, please fill out and submit the following form. All items with an * are required.
|
- Click here to perform a System Check to determine if you can receive Streaming Media.
- If you have problems listening, view our help pages, or click here to contact technical support.
|
|